These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15818162)

  • 1. Molecular markers, molecular-targeted therapies and taxanes: how to integrate the progress into clinical research and practice for the management of head and neck cancers.
    Awada A; Lalami Y
    Curr Opin Oncol; 2005 May; 17(3):209-11. PubMed ID: 15818162
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of docetaxel in treatment of squamous-cell carcinoma of head and neck].
    Subramanian S; Kanagavel D; Petenko NN; Orlova KV; Samoĭlenko IV; Demidov LV
    Vopr Onkol; 2011; 57(4):421-6. PubMed ID: 22191228
    [No Abstract]   [Full Text] [Related]  

  • 3. New treatment for head and neck cancer.
    FDA Consum; 2007; 41(2):5. PubMed ID: 17590894
    [No Abstract]   [Full Text] [Related]  

  • 4. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
    Awada A; Ismael G
    Curr Opin Oncol; 2007 May; 19(3):177-9. PubMed ID: 17414633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers predicting chemotherapy response in head and neck squamous cell carcinoma: a review.
    Cosway B; Paleri V; Wilson J
    J Laryngol Otol; 2015 Nov; 129(11):1046-52. PubMed ID: 26429303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxanes in cancer of the head and neck.
    Misiukiewicz K; Gupta V; Bakst R; Posner M
    Anticancer Drugs; 2014 May; 25(5):561-70. PubMed ID: 24534821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxanes in the treatment of head and neck cancer.
    Schrijvers D; Vermorken JB
    Curr Opin Oncol; 2005 May; 17(3):218-24. PubMed ID: 15818164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.
    Mody MD; Gill HS; Saba NF
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):898-905. PubMed ID: 27389786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives.
    Bozec A; Peyrade F; Milano G
    Anticancer Agents Med Chem; 2013 Mar; 13(3):389-402. PubMed ID: 23092267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in chemotherapy for head and neck cancer.
    Bhide SA; Nutting CM
    Oral Oncol; 2010 Jun; 46(6):436-8. PubMed ID: 20400360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel in the management of patients with head and neck squamous cell carcinoma.
    Bernier J; Vrieling C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1023-32. PubMed ID: 18588449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.
    Le Tourneau C; Siu LL
    Curr Opin Oncol; 2008 May; 20(3):256-63. PubMed ID: 18391623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in head and neck squamous cell carcinoma--a review.
    Safdari Y; Khalili M; Farajnia S; Asgharzadeh M; Yazdani Y; Sadeghi M
    Clin Biochem; 2014 Sep; 47(13-14):1195-202. PubMed ID: 24912050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of taxanes and targeted therapies in locally advanced head and neck cancer.
    Specenier P; Vermorken JB
    Curr Opin Oncol; 2007 May; 19(3):195-201. PubMed ID: 17414636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for squamous-cell carcinoma of the head and neck.
    Papaspyrou G; Werner JA; Dietz A
    Expert Opin Pharmacother; 2011 Feb; 12(3):397-409. PubMed ID: 21254947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel in the management of head and neck cancer.
    Caponigro F; Longo F; Perri F; Ionna F
    Anticancer Drugs; 2009 Sep; 20(8):639-45. PubMed ID: 19639668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging molecular targeted therapies in the treatment of head and neck cancer.
    Bozec A; Peyrade F; Fischel JL; Milano G
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):299-310. PubMed ID: 19519286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
    Van Allen EM; Lui VW; Egloff AM; Goetz EM; Li H; Johnson JT; Duvvuri U; Bauman JE; Stransky N; Zeng Y; Gilbert BR; Pendleton KP; Wang L; Chiosea S; Sougnez C; Wagle N; Zhang F; Du Y; Close D; Johnston PA; McKenna A; Carter SL; Golub TR; Getz G; Mills GB; Garraway LA; Grandis JR
    JAMA Oncol; 2015 May; 1(2):238-44. PubMed ID: 26181029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Docetaxel in the inductive therapy of head and neck cancer: recent evidence].
    Benasso M; Corvò R
    Tumori; 2008; 94(4):suppl 24-5. PubMed ID: 18822713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.